Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Cancer Medicine|March 21, 2022
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND studyGiandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
Clinical Genitourinary Cancer|May 28, 2018
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?Roberto Iacovelli, Ugo De Giorgi, Luca Galli, et al.
Urologic Oncology|April 3, 2019
The effect of a treatment delay on outcome in metastatic renal cell carcinomaRoberto Iacovelli, Luca Galli, Ugo De Giorgi, et al.
Cancer Investigation|February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access programPaolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
The Lancet. Oncology|September 23, 2014
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trialCora N Sternberg, Daniel Castellano, Gedske Daugaard, et al.
Journal of Geriatric Oncology|August 13, 2025
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinomaVeronica Murianni, Marina Campione, Malvina Cremante, et al.
Tumori|April 11, 2022
First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer RegistryLuca Galli, Vincenzo Emanuele Chiuri, Giuseppe Di Lorenzo, et al.
Frontiers in Oncology|October 3, 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trialAndrea Antonuzzo, Carla Ida Ripamonti, Fausto Roila, et al.
Clinical & Experimental Metastasis|June 8, 2024
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 projectAlessandro Rizzo, Sebastiano Buti, Patrizia Giannatempo, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2024
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer careVincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, et al.
Pageof 15